Capital Expenditures for Boston Scientific (BSX)
According to Boston Scientific's latest reported financial statements, the company's current capital expenditures (TTM) is $909.00M USD. Capital expenditures (CapEx) are cash outlays for property, plant, and equipment and other long-lived productive assets — reported on the cash flow statement under investing activities. CapEx funds future capacity (factories, data centers, software, machinery), so rising spend can signal investment in growth, while heavy CapEx reduces free cash flow available to shareholders. We display CapEx as a positive amount (the absolute cash outflow); compare with revenue to gauge capital intensity and with total assets for the asset-base context.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Currently viewingCapital ExpendituresSwitch metric
Latest period
$909.00M
YoY change
+10.9%
5Y CAGR
+18.4%
Peak year (1998)
$2.23B
Cumulative capital expenditures
$12.42B
CapEx history chart for Boston Scientific (BSX) from 1991 to 2025
CapEx history table for Boston Scientific (BSX) from 1991 to 2025
| Fiscal year | Period ended | Reported | Capital Expenditures | YoY |
|---|---|---|---|---|
| 2025 | $876.00M | +10.9% | ||
| 2024 | $790.00M | -1.3% | ||
| 2023 | $800.00M | +30.7% | ||
| 2022 | $612.00M | +10.5% | ||
| 2021 | $554.00M | +47.3% | ||
| 2020 | $376.00M | -18.4% | ||
| 2019 | $461.00M | +45.9% | ||
| 2018 | $316.00M | -0.9% | ||
| 2017 | $319.00M | -15.2% | ||
| 2016 | $376.00M | +52.2% | ||
| 2015 | $247.00M | -4.6% | ||
| 2014 | $259.00M | +5.7% | ||
| 2013 | $245.00M | +8.4% | ||
| 2012 | $226.00M | -25.7% | ||
| 2011 | $304.00M | +9.4% | ||
| 2010 | $278.00M | -23.2% | ||
| 2009 | $362.00M | 0.0% | ||
| 2008 | $362.00M | -0.3% | ||
| 2007 | $363.00M | +6.5% | ||
| 2006 | $341.00M | 0.0% | ||
| 2005 | $341.00M | +24.5% | ||
| 2004 | $274.00M | +45.7% | ||
| 2003 | $188.00M | +67.9% | ||
| 2002 | $112.00M | -7.4% | ||
| 2001 | $121.00M | +59.2% | ||
| 2000 | $76.00M | -5.0% | ||
| 1999 | $80.00M | -96.4% | ||
| 1998 | $2.23B | +837.9% | ||
| 1997 | $238.20M | +76.1% | ||
| 1996 | $135.30M | +96.1% | ||
| 1995 | $69.00M | +92.7% | ||
| 1994 | $35.80M | 0.0% | ||
| 1993 | $35.80M | +244.2% | ||
| 1992 | $10.40M | +42.5% | ||
| 1991 | $7.30M | — |
CapEx values are taken from Boston Scientific's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
As of the 2025 fiscal year, Boston Scientific (BSX) reported capital expenditures of $876.00M – grew 10.9% year-over-year.
Looking at the 2020–2025 (5 years) stretch, Boston Scientific capital expenditures compounded at +18.4% per year, with the latest reading among the more recent periods of the dataset.
Between 1998 and 2025, Boston Scientific capital expenditures plunged 60.8%, falling from $2.23B to $876.00M.
1998 marks the peak capital expenditures at $2.23B, with the historical low of $7.30M recorded in 1991.
Among 8 Healthcare peers, Boston Scientific (BSX) ranks 9th; the peer median for capital expenditures is $3.87B.
Boston Scientific Capital Expenditures by Year
Boston Scientific Capital Expenditures 2025: $876.00M
Boston Scientific capital expenditures in 2025 was $876.00M, grew 10.9% from 2024.
Boston Scientific Capital Expenditures 2024: $790.00M
Boston Scientific capital expenditures in 2024 was $790.00M, edged down 1.3% below 2023.
Boston Scientific Capital Expenditures 2023: $800.00M
Boston Scientific capital expenditures in 2023 was $800.00M, surged 30.7% from 2022.
Boston Scientific Capital Expenditures 2022: $612.00M
Boston Scientific capital expenditures in 2022 was $612.00M, grew 10.5% from 2021.
Boston Scientific Capital Expenditures 2021: $554.00M
Boston Scientific capital expenditures in 2021 was $554.00M.
See more financial history for Boston Scientific (BSX).
Sector peers — CapEx
Companies in the same sector as Boston Scientific, ranked by their latest capital expenditures.
| Company | Capital Expenditures | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $90.11B | Healthcare |
| Eli Lilly and Company (LLY) | $7.84B | Healthcare |
| Johnson & Johnson (JNJ) | $4.83B | Healthcare |
| Merck & Co., Inc. (MRK) | $4.11B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $3.62B | Healthcare |
| AstraZeneca PLC (AZN) | $2.81B | Healthcare |
| Amgen Inc. (AMGN) | $1.86B | Healthcare |
| AbbVie Inc. (ABBV) | $1.21B | Healthcare |
Frequently asked questions
What is Boston Scientific's capital expenditures?
- Latest reported capital expenditures for Boston Scientific (BSX) is $909.00M (period ending December 31, 2025).
How has Boston Scientific capital expenditures changed year-over-year?
- Boston Scientific (BSX) capital expenditures changed +10.9% year-over-year on the latest annual filing.
What is the long-term growth rate of Boston Scientific capital expenditures?
- Boston Scientific (BSX) capital expenditures compound annual growth rate is +18.4% over the most recent 5 years available.
When did Boston Scientific capital expenditures hit its highest annual value?
- Boston Scientific capital expenditures reached its highest annual value of $2.23B in 1998.
What was Boston Scientific capital expenditures in 2024?
- Boston Scientific (BSX) capital expenditures in 2024 was $790.00M.
What was Boston Scientific capital expenditures in 2025?
- Boston Scientific (BSX) capital expenditures in 2025 was $876.00M.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
BSX Overview
Company profile, financial tools, and key metrics
BSX Revenue Counter
Earns $653.70 every second. See per minute, hour, and day.
BSX Earnings Counter
Earns $112.66 per second net profit. See per minute, hour, and day.
BSX Economic Scale
Exceeds Niger's GDP. Compare with world economies.
BSX What If Invested
What if you had invested $1,000? See historical returns from any date.
BSX How It Makes Money
Discover visual breakdown of $20.61B in revenue — where it comes from and where it goes.
BSX Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
BSX Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
BSX Daily Price Character
Balanced · 48.8% historical win rate (green days). Streaks & record days.
BSX Buybacks
Recent repurchase activity. Shareholder yield & SBC comparison.
BSX Stock Split History
2 splits on record. Dates, ratios, and cumulative multiple.